Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: Evidence for agonist-specific trafficking of intracellular responses

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 884-888

  Bonhaus, D W ^a   Chang, L K ^a   Kwan, J ^a   Martin, G R ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; CYCLIC AMP; CYCLOHEXANOL DERIVATIVE; DEXANABINOL; DRUG DERIVATIVE; DRUG RECEPTOR; FORSKOLIN; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; TETRAHYDROCANNABINOL; CANNABINOID RECEPTOR AGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; ARTICLE; CHO CELL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; AGONIST; ANIMAL CELL; BINDING AFFINITY; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; ENZYME INHIBITION; INTRACELLULAR TRANSPORT; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ANIMALS; ARACHIDONIC ACIDS; CHO CELLS; CRICETINAE; CYCLIC AMP; CYCLOHEXANOLS; ENZYME ACTIVATION; FORSKOLIN; HUMANS; MORPHOLINES; NAPHTHALENES; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; TETRAHYDROCANNABINOL; TRANSFECTION;

EID: 0032246648     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Abood ME and Martin BR (1996) Molecular neurobiology of the cannabinoid receptor. Int Rev Neurobiol 39:197-221.
2. Adams IB and Martin BR ( 1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91:1585-1614.
3. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-51X7.
4. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmo la M, Le FG and Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CBj. Biochem J 312:637-641.
5. Cheng YC and Prusoff WH (1973) Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 92:881-894.
6. Childers SR and Deadwyler SA (1996) Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pharmacol 52:819-827.
7. Compton DR, Rice KC, De CB, Razdan RK, Melvin LS, Johnson MR and Martin BR ( 1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
8. Deadwyler SA, Hampson RE, Mu J, Whyte A and Childers S (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther 273:734-743.
9. Eason MO, Jacinto MT and Liggett SB (1994) Contribution of ligand structure to activation of alpha 2-adrenergic receptor subtype coupling to GB. Mol Pharmacol 45:696-702.
10. Eason MG, Kurose H, Holt BD, Raymond JR and Liggett SB (1992) Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4 and alpha 2C2 adrenergic receptors to G; and Gs. J Biol Chem 267:15795-15801.
11. Federman AD, Conklin BR, Schrader KA, Reed RR and Bourne HR (1992) Hormonal stimulation of adenylyl cyclase through Gpprotein y subunits. Nature 356:15£161.
12. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan G-J, Hunden DC, Johnson DW, Chaney MO, Koppel GA and Brownstein M (1995) LY320135, a novel cannabinoid CBj receptor antagonist, unmasks coupling of the CB[ receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284: 291-297.
13. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai, Y, Ma AL ard Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CBj and CB2 receptors. Mol Pharmacol 48:443-450.
14. Glass M and Felder CC (1997) Concurrent stimulation of cannabinoid CB! ard dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CE1 receptor. J. Neurosci 17:5327-5333.
15. Hollister LE (1986) Health aspects of cannabis. Pharm Rev 38:1-20.
16. Howlett AC (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry öftre response in neuroblastoma cell membranes. Mol Pharmacol 27:429-436.
17. Howlett AC (1995) Pharmacology of cannabinoid receptors. Anna Rev Pharmacol Toxicol 35:607-634.
18. Howlett AC and Fleming RM (1984) Cannabinoid inhibition of adenylate cyclasu. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532-538.
19. Kenakin T (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sei 16:232-238.
20. Kenakin T (1997) Agonist-specific receptor conformations. Trends Pharmacol Sei 18:416-417.
21. Maneuf YP and Brotchie JM ( 1997) Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br J Pharmacol 120:1397-1398.
22. Matsuda LA ( 1997) Molecular aspects of cannabinoid receptors. Crit Rev Neurobiol 11:143-166.
23. Matsuda S and Bonner TI (1995) Molecular biology of the cannabinoid receptor i.i Cannabinoid Receptors (Pertwee, RG eds) pp 117-143, Academic Press, San Diego.
24. Negishi M, Sugimoto Y and Ichikawa A (1995) Prostaglandin E receptors. J Lipid Médiat Cell Signal 12:379-391.
25. Pacheco MA, Ward SJ and Childers SR (1994) Differential requirements of sodiuri for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes. J Neurochem 62:1773-1782.
26. Pertwee RG (1995) Pharmacological, physiological and clinical implication of ths discovery of cannabinoid receptors: an overview in Cannabinoid Receptors (Pertwee, RG eds) pp 2-29, Academic Press, San Diego.
27. Pieroni JP, Jacobowitz O, Chen J and lyengar R (1993) Signal recognition ami integration by Gs-stimulated adenylyl cyclases. Curr Opin Neurobiol 3:345-351.
28. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martine? S, Maruani J, Neliat G, Caput D and et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
29. Song ZH and Bonner TI (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mot Pharmacol 49:891-896.
30. Sunahara RK, Dessauer CW and Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480.
31. Sutkowski EM, Tang WJ, Broome CW, Robbing JD and Seamon KB (1994) Regulation of forskolin interactions with type I, II, V and VI adenylyl cyclases by G. alpha. Biochem 33:12852-12859.
32. Twitchell W, Brown S and Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78:43-50